Search

Aileen Hoehne

age ~46

from Fremont, CA

Get Report
Also known as:
  • Aileen Hohne
Phone and address:
3760 Warwick Rd, Fremont, CA 94555
Related to:
Connected to:

Aileen Hoehne Phones & Addresses

  • 3760 Warwick Rd, Fremont, CA 94555
  • Mountain View, CA

Work

  • Company:
    Stanford university
    Sep 2011
  • Position:
    Research scientist

Education

  • Degree:
    PhD
  • School / High School:
    Eidgenössische Technische Hochschule Zürich
    2004 to 2008
  • Specialities:
    Radiopharmacy

Skills

In Vitro • Cell Culture • Organic Chemistry • In Vivo • Chemistry • Radiochemistry • Assay Development • Small Animal Imaging • Autoradiography • GMP

Languages

English • German • French • Russian

Awards

Young scientist award - 19th international symposium on radiopharmaceutical sciences • Travel grant - 17th international symposium on radiopharmaceutical sciences • High school graduate award - German chemical society (gdch)

Industries

Higher Education

Us Patents

  • Multi-Modality Molecular Imaging High-Throughput Assay For Identifying Heat Shock Protein 90 (Hsp90) Inhibitors

    view source
  • US Patent:
    20130310347, Nov 21, 2013
  • Filed:
    May 21, 2013
  • Appl. No.:
    13/898637
  • Inventors:
    Sanjiv S. Gambhir - Portola Valley CA, US
    David E. Solow-Cordero - San Francisco CA, US
    Aileen Hoehne - Fremont CA, US
  • Assignee:
    The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
  • International Classification:
    C07D 473/08
    C07C 311/38
    C07D 413/14
    C07D 213/75
    C07D 213/65
    C07D 213/42
    C07D 513/04
    C07D 213/81
  • US Classification:
    514156, 544273, 51426334, 548154, 514368, 564 86, 514155, 546262, 514332, 546309, 514352, 546291, 514346, 544267, 546338, 514357, 544318, 514274, 546234, 435 8
  • Abstract:
    High throughput methods for identifying novel inhibitors of Hsp90 chaperone protein folding are disclosed. The inhibitors so identified disrupt the binding of p23 to either Hsp90α or Hsp90β and have selective activity against the proliferation of cancer cells. In particular are provided embodiments of therapeutic compositions that comprise at least one inhibitor of an Hsp90 chaperone activity, the inhibitor being any of the compounds designated as CP1-CP19 as shown in FIGS. A-D or a 2-(trifluoromethyl)pyrimidin-2-yl)thio)acetamide derivatives.

Resumes

Aileen Hoehne Photo 1

Research Scientist At Stanford University

view source
Position:
Research Scientist at Stanford University
Location:
San Francisco Bay Area
Industry:
Higher Education
Work:
Stanford University since Sep 2011
Research Scientist
Stanford University Apr 2009 - Aug 2011
Postdoc
Eidgenössische Technische Hochschule Zürich Oct 2004 - Mar 2008
PhD student
Forschungszentrum Dresden-Rossendorf Sep 2003 - Jun 2004
Master student
Education:
Eidgenössische Technische Hochschule Zürich 2004 - 2008
PhD, Radiopharmacy Technische Universität Dresden 1998 - 2004
Diploma, Chemistry
Skills:
In Vitro
Cell Culture
Organic Chemistry
In Vivo
Chemistry
Radiochemistry
Assay Development
Small Animal Imaging
Autoradiography
GMP
Languages:
English
German
French
Russian
Awards:
Young Scientist Award
19th International Symposium on Radiopharmaceutical Sciences
Travel grant
17th International Symposium on Radiopharmaceutical Sciences
High School Graduate Award
German Chemical Society (GDCh)
Get Report for Aileen Hoehne from Fremont, CA, age ~46
Control profile